35
Participants
Start Date
November 30, 2018
Primary Completion Date
June 30, 2024
Study Completion Date
June 30, 2025
Rituximab
500 mg/m2 + 5%DW 500 mL IVF Begin with 50 mg/hr (increase by 50 mg/hr per 30 min until 400 mg/hr is reached)
Methotrexate
500 mg/m2 + 5%DW 200 mL IV over 15 minutes 3000 mg/m2 + 5%DW 500 mL IVF over 3 hrs Concurrent hydration and subsequent leucovorin rescue is mandatory
Cytarabine Injection
3000 mg/m2 + 5%DW 200 mL IVF over 2 hrs steroid eye drop 0.1%, 2 drops q 6hrs, on days 1-9
RECRUITING
Samsung Medical Center, Seoul
Collaborators (1)
Celltrion
INDUSTRY
Won Seog Kim
OTHER